The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Arun Azad
Honoraria - Aculeus Therapeutics; Amgen; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Daiichi Sankyo; Ipsen; Janssen; Merck Serono; Merck Sharp & Dohme; Novartis; Noxopharm; Pfizer; Sanofi; Telix Pharmaceuticals; Tolmar
Consulting or Advisory Role - Aculeus Therapeutics; Amgen; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Daiichi Sankyo; Ipsen; Janssen; Merck Serono; Merck Sharp & Dohme; Novartis; Noxopharm; Pfizer; Sanofi; Telix Pharmaceuticals; Tolmar
Speakers' Bureau - Amgen; Astellas Pharma; Bayer; Bristol-Myers Squibb; Ipsen; Janssen; Merck Serono; Novartis
Research Funding - Aptevo Therapeutics (Inst); Astellas Pharma; Astellas Pharma (Inst); AstraZeneca; AstraZeneca (Inst); Bionomics (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Hinova Pharmaceuticals (Inst); Ipsen (Inst); Janssen (Inst); Lilly (Inst); MedImmune (Inst); Merck Serono; Merck Serono (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Sanofi (Inst); Synthorx (Inst)
Travel, Accommodations, Expenses - Amgen; Astellas Pharma; Bayer; Hinova Pharmaceuticals; Janssen; Merck Serono; Pfizer; Sanofi; Tolmar
 
Patrick Pilié
Consulting or Advisory Role - Novartis; Pfizer
Patents, Royalties, Other Intellectual Property - Patent Pending- biomarker
 
Mark Voskoboynik
Honoraria - MSD
Consulting or Advisory Role - AstraZeneca; MSD
Research Funding - Alpine Immune Sciences (Inst); Antengene (Inst); AstraZeneca (Inst); AstraZeneca/MedImmune (Inst); Atridia (Inst); BeiGene (Inst); Hengrui Pharmaceutical (Inst); Hinova Pharmaceuticals (Inst); Immunocore (Inst); MSD (Inst); Virocore (Inst)
 
Frank Cackowski
Honoraria - GU Oncology Now, Mashup Media LLC
 
Andrew Weickhardt
No Relationships to Disclose
 
Elena Verzoni
Honoraria - Eisai; Ipsen; Janssen; MSD Oncology; Novartis
Consulting or Advisory Role - Janssen Oncology; MSD/AstraZeneca; Pfizer
 
Anthony Joshua
Consulting or Advisory Role - Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Eisai (Inst); Grey Wolf Therapeutics (Inst); IDEAYA Biosciences (Inst); Ipsen (Inst); IQvia (Inst); Janssen Oncology (Inst); Mayne Pharma (Inst); Medison (Inst); Merck Serono (Inst); MSD Oncology (Inst); Novartis (Inst); Pfizer (Inst); Sanofi (Inst); Starpharma (Inst)
Research Funding - AstraZeneca (Inst); Bayer (Inst); BeiGene (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Immunocore (Inst); Janssen Oncology (Inst); Lilly (Inst); Lilly (Inst); Mayne Pharma (Inst); Merck Sharp & Dohme (Inst); Myeloid Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Patents, Royalties, Other Intellectual Property - Cancer therapeutic methods; Use of Darovasertib for Neoadjuvant treatment ocular Melanoma
 
Neal Shore
Stock and Other Ownership Interests - Photocure
Consulting or Advisory Role - Accord Research; Alessa Therapeutics; Amgen; Antev; Asieris Pharmaceuticals; Astellas Pharma; AstraZeneca; Aura Biosciences; Bayer; Bioprotect; Bristol-Myers Squibb/Sanofi; CG Oncology; Clarity Pharmaceuticals; Dendreon; Exact Imaging; Ferring; Fize Medical; Glytherix; ImmunityBio; InVitae; Janssen Scientific Affairs; Lantheus Medical Imaging; Lilly; MDxHealth; Medivation/Astellas; Merck; Minomic; Myriad Genetics; Novartis; Nusano; Pfizer; Photocure; PlatformQ Health; Promaxo; Protara Therapeutics; Sanofi; Siemens; Speciality Networks; Sumitomo Pharma Oncology; Telix Pharmaceuticals; Tolmar; Tutelix; Urogen pharma
Research Funding - Abbvie; Advantagene; Amgen; Aragon Pharmaceuticals; Astellas Pharma; AstraZeneca; Bayer; Boston Scientific; Bristol-Myers Squibb/Pfizer; CG Oncology; Clovis Oncology; Dendreon; DisperSol; Endocyte; Exact Imaging; Exelixis; Ferring; FKD Therapies; FORMA Therapeutics; Foundation Medicine; Genentech; Guardant Health; InVitae; Istari Oncology; Janssen; Jiangsu Yahong Meditech; MDxHealth; Medivation; Merck; MT Group; Myovant Sciences; Myriad Genetics; Novartis; Nymox; OncoCellMDx; ORIC Pharmaceuticals; pacific edge; Palette Life Sciences; Pfizer; Plexxikon; POINT Biopharma; Propella Therapeutics; Propella Therapeutics; RhoVac; Sanofi; SeaGen; Sesen Bio; Steba Biotech; Theralase; Tolmar; Urogen pharma; Urotronic; US Biotest; Vaxiion; Veru; Zenflow
 
Laurence Krieger
No Relationships to Disclose
 
Marco Maruzzo
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Eisai; Exelx; Janssen; Merck Serono; MSD Oncology; Pfizer
Travel, Accommodations, Expenses - Ipsen; Janssen
 
Eleni Efstathiou
Honoraria - Astellas Pharma; Janssen-Cilag; Merck; Pfizer; Sanofi; Takeda
Consulting or Advisory Role - AstraZeneca; AstraZeneca; Bayer; Janssen Oncology; Myovant Sciences; Sanofi; Tokai Pharmaceuticals
Research Funding - Janssen-Cilag
 
Peter Sankey
Speakers' Bureau - Astellas Pharma
Travel, Accommodations, Expenses - Bayer; Trinetx
 
Simon Pacey
Consulting or Advisory Role - AstraZeneca; Elsevier; Roche/Genentech
Research Funding - AstraZeneca (Inst); AstraZeneca/MedImmune (Inst); Guardant Health (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Vanesa Gregorc
Consulting or Advisory Role - Bristol-Myers Squibb; Daiichi Sankyo; Pierre Fabre; Regeneron
Speakers' Bureau - Amgen; AstraZeneca; Bristol-Myers Squibb; Lilly; MSD; Roche
Travel, Accommodations, Expenses - GreenFleet; MSD; Pierre Fabre
 
Christopher Pieczonka
Employment - Associated Medical Professionals of New York
Leadership - Associated Medical Professionals of New York; US UROLOGY PARTNERS; US UROLOGY PARTNERS
Stock and Other Ownership Interests - ImmunityBio; US Urology Partners
Honoraria - AstraZeneca; Bayer; Bristol-Myers Squibb; Dendreon; ImmunityBio; Janssen; Merck; Myovant Sciences; Novartis; Pfizer/Astellas; Sun Pharma
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Dendreon; ImmunityBio; ImmunityBio; Janssen Oncology; Merck; Novartis; Pfizer/Astellas; Sun Pharma; Sun Pharma; Tolmar
Speakers' Bureau - Astellas Pharma; Astra Zenerca; Bayer; Dendreon; Janssen Oncology; Merck; Myovant Sciences; Pfizer; Sun Pharma
Research Funding - Advantagene; Astellas Pharma; AstraZeneca; Bayer; Candel Therapeutics (Inst); CG Oncology (Inst); Dendreon; ImmunityBio (Inst); InVitae; InVitae; Janssen Oncology; Merck; Pfizer
 
Lydia Kate Dickson
Employment - AstraZeneca
 
Younghwa Kim
Employment - AstraZeneca
 
Bruno de Paula
Employment - AstraZeneca
 
Tsveta Milenkova
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Andrew Hudson
Honoraria - AstraZeneca; Janssen; Merck Serono; Novartis; Pfizer
Consulting or Advisory Role - AstraZeneca; Janssen; Pfizer
Travel, Accommodations, Expenses - Merck Serono